Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$758M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$460M |
| 3 |
Adobe
ADBE
|
+$352M |
| 4 |
Intercontinental Exchange
ICE
|
+$327M |
| 5 |
Ferguson
FERG
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.47B |
| 2 |
Cisco
CSCO
|
+$1.1B |
| 3 |
NVIDIA
NVDA
|
+$1.01B |
| 4 |
Microsoft
MSFT
|
+$914M |
| 5 |
Apple
AAPL
|
+$753M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.36% |
| 2 | Financials | 13.6% |
| 3 | Healthcare | 11.34% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Hyperfine
HYPR
$94.7M
| $123K | ﹤0.01% |
171,495
| – | – |
|
3852
The ONE Group
STKS
$56.8M
| $123K | ﹤0.01% |
41,053
| – | – |
|
3853
InnovAge Holding
INNV
$1.45B
| $122K | ﹤0.01% |
40,970
+978
| +2% | +$3.38K |
|
3854
TScan Therapeutics
TCRX
$52.3M
| $122K | ﹤0.01% |
88,142
-172
| -0.2% | -$372 |
|
|
RAPT
3855
DELISTED
RAPT Therapeutics
RAPT
| $120K | ﹤0.01% |
12,338
+1,070
| +9% | +$10.5K |
|
3856
Bioceres Crop Solutions
BIOX
$27.4M
| $119K | ﹤0.01% |
26,151
+1
| +0% | +$6 |
|
|
MRSN
3857
DELISTED
Mersana Therapeutics
MRSN
| $119K | ﹤0.01% |
13,848
| – | – |
|
3858
Harvard Bioscience
HBIO
$30.4M
| $119K | ﹤0.01% |
20,955
| – | – |
|
|
NINE
3859
DELISTED
Nine Energy Service
NINE
| $117K | ﹤0.01% |
103,594
| – | – |
|
|
NOTE
3860
DELISTED
FiscalNote
NOTE
| $116K | ﹤0.01% |
11,929
+2,530
| +27% | +$38.1K |
|
3861
Tenaya Therapeutics
TNYA
$164M
| $114K | ﹤0.01% |
200,304
-542
| -0.3% | -$535 |
|
3862
LiveOne
LVO
$59.4M
| $114K | ﹤0.01% |
16,304
-75
| -0.5% | -$739 |
|
|
OPTN
3863
DELISTED
OptiNose
OPTN
| $112K | ﹤0.01% |
12,178
| – | – |
|
|
RDNW
3864
RideNow Group
RDNW
$241M
| $111K | ﹤0.01% |
39,441
+1,061
| +3% | +$4.37K |
|
3865
Quest Resource Holding
QRHC
$30.8M
| $111K | ﹤0.01% |
42,732
-140
| -0.3% | -$663 |
|
3866
Zura Bio
ZURA
$540M
| $111K | ﹤0.01% |
85,917
| – | – |
|
3867
CervoMed
CRVO
$39.6M
| $110K | ﹤0.01% |
+12,028
| New | +$45.8K |
|
3868
Jasper Therapeutics
JSPR
$28.7M
| $108K | ﹤0.01% |
25,027
-51
| -0.2% | -$339 |
|
3869
Alto Neuroscience
ANRO
$1.26B
| $107K | ﹤0.01% |
49,545
-2,726
| -5% | -$9.76K |
|
3870
Greenwich LifeSciences
GLSI
$240M
| $107K | ﹤0.01% |
11,203
| – | – |
|
|
HLVX
3871
DELISTED
HilleVax
HLVX
| $105K | ﹤0.01% |
72,690
-70
| -0.1% | -$129 |
|
3872
Actinium Pharmaceuticals
ATNM
$30.2M
| $105K | ﹤0.01% |
65,311
| – | – |
|
3873
Lee Enterprises
LEE
$181M
| $105K | ﹤0.01% |
10,112
| – | – |
|
3874
Caesarstone
CSTE
$105M
| $104K | ﹤0.01% |
42,993
| – | – |
|
|
MCN
3875
Madison Covered Call & Equity Strategy Fund
MCN
$119M
| $104K | ﹤0.01% |
+16,884
| New | +$109K |
|
Similar funds
Bank of New York Mellon's Q1 2025 Portfolio in Review
As of Q1 2025, Bank of New York Mellon held 4,232 positions worth $505B, down 6.7% from $541B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Bank of New York Mellon withdrew a net $15.2B in Q1 2025, closing 122 positions and reducing 2,490 holdings. Its most notable exit was Invesco S&P 500 Pure Value ETF, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of New York Mellon opened a new position in BNY Mellon Dynamic Value ETF worth $138M.
- Bank of New York Mellon's largest Q1 2025 buy was BNY Mellon Dynamic Value ETF: 5,452,259 shares worth $138M.
- Bank of New York Mellon added most to Johnson & Johnson in Q1 2025, an estimated $758M increase.
- Bank of New York Mellon's biggest Q1 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.47B.
- Bank of New York Mellon fully exited Invesco S&P 500 Pure Value ETF in Q1 2025, selling an estimated $123M.
- Bank of New York Mellon's ten largest holdings make up 23% of its $505B portfolio in Q1 2025.
- Bank of New York Mellon opened 116 new positions and closed 122 in Q1 2025.
- Bank of New York Mellon's portfolio value fell 6.7% quarter-over-quarter to $505B.
Based on Bank of New York Mellon's 13F filing for Q1 2025, filed 29 Apr 2025.